{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:50:02Z","timestamp":1782892202171,"version":"3.54.5"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12015-025-11040-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T23:36:47Z","timestamp":1766187407000},"page":"847-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Harnessing MSC Immunomodulation in Orthopedics: Clinical Insights for Comorbidities"],"prefix":"10.1007","volume":"22","author":[{"given":"Mehdi","family":"Rasouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy T.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Wenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"11040_CR1","first-page":"347","volume":"20","author":"NH Hart","year":"2020","unstructured":"Hart, N. H., Newton, R. U., Tan, J., Rantalainen, T., Chivers, P., Siafarikas, A., & Nimphius, S. (2020). Biological basis of bone strength: Anatomy, physiology and measurement. Journal of Musculoskeletal and Neuronal Interactions, 20, 347\u2013371. PMID: 32877972.","journal-title":"Journal of Musculoskeletal and Neuronal Interactions"},{"key":"11040_CR2","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.3928\/01477447-20240913-02","volume":"48","author":"BS Ernst","year":"2025","unstructured":"Ernst, B. S., Kiritsis, N. R., Wyatt, P. B., Reiter, C. R., O\u2019Neill, C. N., Satalich, J. R., & Vap, A. R. (2025). Ranking the orthopedic procedures with the highest morbidity and mortality. Orthopedics, 48, e40\u2013e44. https:\/\/doi.org\/10.3928\/01477447-20240913-02","journal-title":"Orthopedics"},{"key":"11040_CR3","doi-asserted-by":"publisher","first-page":"102935","DOI":"10.1016\/j.artmed.2024.102935","volume":"155","author":"L Alzubaidi","year":"2024","unstructured":"Alzubaidi, L., Al-Dulaimi, K., Salhi, A., Alammar, Z., Fadhel, M. A., Albahri, A. S., Alamoodi, A. H., et al. (2024). Comprehensive review of deep learning in orthopaedics: Applications, challenges, trustworthiness, and fusion. Artificial intelligence in Medicine, 155, 102935. https:\/\/doi.org\/10.1016\/j.artmed.2024.102935","journal-title":"Artificial intelligence in Medicine"},{"key":"11040_CR4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan, A. I. (2017). Mesenchymal stem cells: Time to change the Name! Stem Cells Transl Med, 6, 1445\u20131451. https:\/\/doi.org\/10.1002\/sctm.17-0051","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcyt.2024.10.008","volume":"27","author":"L Renesme","year":"2025","unstructured":"Renesme, L., Cobey, K. D., Lalu, M. M., Bubela, T., Chinnadurai, R., De Vos, J., Dunbar, R., et al. (2025). Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics. Cytotherapy, 27, 146\u2013168. https:\/\/doi.org\/10.1016\/j.jcyt.2024.10.008","journal-title":"Cytotherapy"},{"key":"11040_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K., Martin, I., Nolta, J., et al. (2019). Mesenchymal stem versus stromal cells: International society for cell & gene therapy (ISCT\u00ae) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy, 21, 1019\u20131024. https:\/\/doi.org\/10.1016\/j.jcyt.2019.08.002","journal-title":"Cytotherapy"},{"key":"11040_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143\u2013147. https:\/\/doi.org\/10.1126\/science.284.5411.143","journal-title":"Science"},{"key":"11040_CR8","doi-asserted-by":"publisher","first-page":"591065","DOI":"10.3389\/fimmu.2020.591065","volume":"11","author":"S Dabrowska","year":"2020","unstructured":"Dabrowska, S., Andrzejewska, A., Janowski, M., & Lukomska, B. (2020). Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: Therapeutic outlook for inflammatory and degenerative diseases. Frontiers in Immunology, 11, 591065. https:\/\/doi.org\/10.3389\/fimmu.2020.591065","journal-title":"Frontiers in Immunology"},{"key":"11040_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8, 315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"11040_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","volume":"15","author":"M Ullah","year":"2019","unstructured":"Ullah, M., Liu, D. D., & Thakor, A. S. (2019). Mesenchymal stromal cell homing: Mechanisms and strategies for improvement. iScience, 15, 421\u2013438. https:\/\/doi.org\/10.1016\/j.isci.2019.05.004","journal-title":"iScience"},{"key":"11040_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.01.005","author":"KL Blanc","year":"2025","unstructured":"Blanc, K. L., Dazzi, F., English, K., Farge, D., Galipeau, J., Horwitz, E. M., Kadri, N., et al. (2025). ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells. Cytotherapy. https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.005","journal-title":"Cytotherapy"},{"key":"11040_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan, A. I. (2009). Why are MSCs therapeutic? New data: New insight. The Journal of Pathology, 217, 318\u2013324. https:\/\/doi.org\/10.1002\/path.2469","journal-title":"The Journal of Pathology"},{"key":"11040_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/jgm.452","volume":"5","author":"A Chapel","year":"2003","unstructured":"Chapel, A., Bertho, J. M., Bensidhoum, M., Fouillard, L., Young, R. G., Frick, J., Demarquay, C., et al. (2003). Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. The Journal of Gene Medicine, 5, 1028\u20131038. https:\/\/doi.org\/10.1002\/jgm.452","journal-title":"The Journal of Gene Medicine"},{"key":"11040_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nbt0318-212a","volume":"36","author":"C Sheridan","year":"2018","unstructured":"Sheridan, C. (2018). First off-the-shelf mesenchymal stem cell therapy nears European approval. Nature Biotechnology, 36, 212\u2013214. https:\/\/doi.org\/10.1038\/nbt0318-212a","journal-title":"Nature Biotechnology"},{"key":"11040_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fbioe.2020.00043","volume":"8","author":"A Hmadcha","year":"2020","unstructured":"Hmadcha, A., Martin-Montalvo, A., Gauthier, B. R., Soria, B., & Capilla-Gonzalez, V. (2020). Therapeutic potential of mesenchymal stem cells for cancer therapy. Frontiers in Bioengineering and Biotechnology, 8, 43. https:\/\/doi.org\/10.3389\/fbioe.2020.00043","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"11040_CR16","doi-asserted-by":"publisher","first-page":"984984","DOI":"10.3389\/fimmu.2022.984984","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z., Sun, Y., Shen, R., Tang, X., Xu, Y., Zhang, Y., & Liu, Y. (2022). Global scientific trends on the Immunomodulation of mesenchymal stem cells in the 21st century: A bibliometric and visualized analysis. Frontiers in Immunology, 13, 984984. https:\/\/doi.org\/10.3389\/fimmu.2022.984984","journal-title":"Frontiers in Immunology"},{"key":"11040_CR17","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s10924-025-03571-y","volume":"33","author":"S Hosseinzadeh","year":"2025","unstructured":"Hosseinzadeh, S., Shahghasempour, L., Abbaszadeh, H. A., Soleimani, M., Abdollahifar, M. A., Rasouli, M., Khani, M. M., et al. (2025). In vivo model of bone regeneration with aspirin Cross-linked O-carboxymethyl Chitosan hydrogel loaded with adipose Derived-Stem cells. Journal of Polymers and the Environment, 33, 2931\u20132945. https:\/\/doi.org\/10.1007\/s10924-025-03571-y","journal-title":"Journal of Polymers and the Environment"},{"key":"11040_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00403-024-03082-1","volume":"316","author":"M Rasouli","year":"2024","unstructured":"Rasouli, M., Shahghasempour, L., Shirbaghaee, Z., Hosseinzadeh, S., Abbaszadeh, H. A., Fattahi, R., Ranjbari, J., et al. (2024). Mesenchymal stem cell therapy using Pal-KTTKS-enriched carboxylated cellulose improves burn wound in rat model. Archives of Dermatological Research, 316, 353. https:\/\/doi.org\/10.1007\/s00403-024-03082-1","journal-title":"Archives of Dermatological Research"},{"key":"11040_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-023-03390-9","volume":"14","author":"Z Shirbaghaee","year":"2023","unstructured":"Shirbaghaee, Z., Heidari Keshel, S., Rasouli, M., Valizadeh, M., Hashemi Nazari, S. S., Hassani, M., & Soleimani, M. (2023). Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI). Stem Cell Research & Therapy, 14, 174. https:\/\/doi.org\/10.1186\/s13287-023-03390-9","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR20","doi-asserted-by":"publisher","first-page":"3162743","DOI":"10.1155\/2016\/3162743","volume":"2016","author":"RA Contreras","year":"2016","unstructured":"Contreras, R. A., Figueroa, F. E., Djouad, F., & Luz-Crawford, P. (2016). Mesenchymal stem cells regulate the innate and adaptive immune responses dampening arthritis progression. Stem Cells Int, 2016, 3162743. https:\/\/doi.org\/10.1155\/2016\/3162743","journal-title":"Stem Cells Int"},{"key":"11040_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-019-0202-0","volume":"6","author":"KB Thompson","year":"2019","unstructured":"Thompson, K. B., Krispinsky, L. T., & Stark, R. J. (2019). Late immune consequences of combat trauma: A review of trauma-related immune dysfunction and potential therapies. Mil Med Res, 6, 11. https:\/\/doi.org\/10.1186\/s40779-019-0202-0","journal-title":"Mil Med Res"},{"key":"11040_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English, K. (2013). Mechanisms of mesenchymal stromal cell Immunomodulation. Immunology and Cell Biology, 91, 19\u201326. https:\/\/doi.org\/10.1038\/icb.2012.56","journal-title":"Immunology and Cell Biology"},{"key":"11040_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.molimm.2023.11.006","volume":"164","author":"A Mahajan","year":"2023","unstructured":"Mahajan, A., & Bhattacharyya, S. (2023). Immunomodulation by mesenchymal stem cells during osteogenic differentiation: Clinical implications during bone regeneration. Molecular Immunology, 164, 143\u2013152. https:\/\/doi.org\/10.1016\/j.molimm.2023.11.006","journal-title":"Molecular Immunology"},{"key":"11040_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13287-024-03980-1","volume":"15","author":"L Vaillant","year":"2024","unstructured":"Vaillant, L., Akhter, W., Nakhle, J., Simon, M., Villalba, M., Jorgensen, C., Vignais, M. L., et al. (2024). The role of mitochondrial transfer in the suppression of CD8(+) T cell responses by mesenchymal stem cells. Stem Cell Research & Therapy, 15, 394. https:\/\/doi.org\/10.1186\/s13287-024-03980-1","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/PRS.0b013e3181954d08","volume":"123","author":"S El-Ftesi","year":"2009","unstructured":"El-Ftesi, S., Chang, E. I., Longaker, M. T., & Gurtner, G. C. (2009). Aging and diabetes impair the neovascular potential of adipose-derived stromal cells. Plastic and Reconstructive Surgery, 123, 475\u2013485. https:\/\/doi.org\/10.1097\/PRS.0b013e3181954d08","journal-title":"Plastic and Reconstructive Surgery"},{"key":"11040_CR26","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1002\/jcp.26804","volume":"233","author":"B Ulum","year":"2018","unstructured":"Ulum, B., Teker, H. T., Sarikaya, A., Balta, G., Kuskonmaz, B., Uckan-Cetinkaya, D., & Aerts-Kaya, F. (2018). Bone marrow mesenchymal stem cell donors with a high body mass index display elevated Endoplasmic reticulum stress and are functionally impaired. Journal of Cellular Physiology, 233, 8429\u20138436. https:\/\/doi.org\/10.1002\/jcp.26804","journal-title":"Journal of Cellular Physiology"},{"key":"11040_CR27","doi-asserted-by":"publisher","first-page":"101686","DOI":"10.1016\/j.bonr.2023.101686","volume":"19","author":"L Steppe","year":"2023","unstructured":"Steppe, L., Megafu, M., Tschaffon-M\u00fcller, M. E. A., Ignatius, A., & Haffner-Luntzer, M. (2023). Fracture healing research: Recent insights. Bone Rep, 19, 101686. https:\/\/doi.org\/10.1016\/j.bonr.2023.101686","journal-title":"Bone Rep"},{"key":"11040_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/bloodadvances.2024014171","volume":"9","author":"M Battiwalla","year":"2025","unstructured":"Battiwalla, M., Tees, M., Flinn, I., Pantin, J., Berdeja, J., Gregory, T., Maris, M., et al. (2025). Access barriers to anti-CD19\u2009+\u2009CART therapy for NHL across a community transplant and cellular therapy network. Blood Adv, 9, 429\u2013435. https:\/\/doi.org\/10.1182\/bloodadvances.2024014171","journal-title":"Blood Adv"},{"key":"11040_CR29","doi-asserted-by":"publisher","first-page":"e13267","DOI":"10.1111\/sji.13267","volume":"97","author":"W Chen","year":"2023","unstructured":"Chen, W., Lv, L., Chen, N., & Cui, E. (2023). Immunogenicity of mesenchymal stromal\/stem cells. Scandinavian Journal of Immunology, 97, e13267. https:\/\/doi.org\/10.1111\/sji.13267","journal-title":"Scandinavian Journal of Immunology"},{"key":"11040_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bmb\/ldt031","volume":"108","author":"SM Watt","year":"2013","unstructured":"Watt, S. M., Gullo, F., van der Garde, M., Markeson, D., Camicia, R., Khoo, C. P., & Zwaginga, J. J. (2013). The angiogenic properties of mesenchymal stem\/stromal cells and their therapeutic potential. British Medical Bulletin, 108, 25\u201353. https:\/\/doi.org\/10.1093\/bmb\/ldt031","journal-title":"British Medical Bulletin"},{"key":"11040_CR31","doi-asserted-by":"publisher","unstructured":"Oreffo, R. O., Cooper, C., Mason, C., & Clements, M. (2005). Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Reviews, 1. https:\/\/doi.org\/10.1385\/scr:1:2:169. :169\u2009\u2013\u200978.","DOI":"10.1385\/scr:1:2:169"},{"key":"11040_CR32","doi-asserted-by":"publisher","first-page":"6580","DOI":"10.1016\/j.biomaterials.2013.05.056","volume":"34","author":"J He","year":"2013","unstructured":"He, J., Jiang, B., Dai, Y., Hao, J., Zhou, Z., Tian, Z., Wu, F., et al. (2013). Regulation of the osteoblastic and chondrocytic differentiation of stem cells by the extracellular matrix and subsequent bone formation modes. Biomaterials, 34, 6580\u20136588. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.05.056","journal-title":"Biomaterials"},{"key":"11040_CR33","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1016\/j.biomaterials.2013.08.054","volume":"34","author":"G Yang","year":"2013","unstructured":"Yang, G., Rothrauff, B. B., Lin, H., Gottardi, R., Alexander, P. G., & Tuan, R. S. (2013). Enhancement of tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix. Biomaterials, 34, 9295\u20139306. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.08.054","journal-title":"Biomaterials"},{"key":"11040_CR34","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3727\/096368915x687219","volume":"24","author":"S Huang","year":"2015","unstructured":"Huang, S., Xu, L., Zhang, Y., Sun, Y., & Li, G. (2015). Systemic and local administration of allogeneic bone Marrow-Derived mesenchymal stem cells promotes fracture healing in rats. Cell Transplantation, 24, 2643\u20132655. https:\/\/doi.org\/10.3727\/096368915x687219","journal-title":"Cell Transplantation"},{"key":"11040_CR35","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/stem.103","volume":"27","author":"F Granero-Molt\u00f3","year":"2009","unstructured":"Granero-Molt\u00f3, F., Weis, J. A., Miga, M. I., Landis, B., Myers, T. J., O\u2019Rear, L., Longobardi, L., et al. (2009). Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells, 27, 1887\u20131898. https:\/\/doi.org\/10.1002\/stem.103","journal-title":"Stem Cells"},{"key":"11040_CR36","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.injury.2015.04.031","volume":"46","author":"T Shimizu","year":"2015","unstructured":"Shimizu, T., Akahane, M., Morita, Y., Omokawa, S., Nakano, K., Kira, T., Onishi, T., et al. (2015). The regeneration and augmentation of bone with injectable osteogenic cell sheet in a rat critical fracture healing model. Injury, 46, 1457\u20131464. https:\/\/doi.org\/10.1016\/j.injury.2015.04.031","journal-title":"Injury"},{"key":"11040_CR37","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1136\/annrheumdis-2018-eular.4728","volume":"77","author":"N Lozano-Rivas","year":"2018","unstructured":"Lozano-Rivas, N., Marras-Fernandez-Cid, L. F. L. C., Garcia-Hernandez, A. M., Alguer\u00f3, M. D. C., Iniesta, F., Sanchez-Salinas, D., L\u00f3pez-Lucas, M. D., Rodriguez-Valiente, M., Caba\u00f1as, V., Garc\u00eda-Bernal, D., Molina, M. D. M., Lopez, S., Ramirez-Tovar, F., Ruiz Sar\u00e1, J. E., Garc\u00eda, B., Blanquer, M., Olmo Fernandez-Delgado, J. A., Espinosa, M., Zamarro, J., Becerra-Ratia, J., Peris, J. L., L\u00f3pez-Exposito, I., Bafalliu, J. A., Ruiz-Espejo, F., Domenech, E., Morales-Cano, M. D., Arrabal, P. M., Soler, G., Vera, A., Guzman-Aroca, F., Moraleda, J. M., & Sackstein, R. (2018). AB1011 clinical trial of intravenous infusion of fucosylated bone marrow mesenchymal stem cells in patients with osteoporosis. Annals of the Rheumatic Diseases, 77, 1625. https:\/\/doi.org\/10.1136\/annrheumdis-2018-eular.4728","journal-title":"Annals of the Rheumatic Diseases"},{"key":"11040_CR38","doi-asserted-by":"publisher","first-page":"109365","DOI":"10.1016\/j.cellsig.2019.109365","volume":"63","author":"M Ma","year":"2019","unstructured":"Ma, M., Fu, Y., Zhou, X., Guan, F., Wang, Y., & Li, X. (2019). Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis. Cellular Signalling, 63, 109365. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109365","journal-title":"Cellular Signalling"},{"key":"11040_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40778-023-00232-5","volume":"10","author":"AC Bryan Le","year":"2024","unstructured":"Bryan Le, A. C., Morales, D., Fernando, A., & Fierro (2024). First clinical experiences using preconditioning approaches to improve MSC-Based therapies. Current Stem Cell Reports, 10, 1\u20137. https:\/\/doi.org\/10.1007\/s40778-023-00232-5","journal-title":"Current Stem Cell Reports"},{"key":"11040_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","volume":"14","author":"R Sackstein","year":"2008","unstructured":"Sackstein, R., Merzaban, J. S., Cain, D. W., Dagia, N. M., Spencer, J. A., Lin, C. P., & Wohlgemuth, R. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nature Medicine, 14, 181\u2013187. https:\/\/doi.org\/10.1038\/nm1703","journal-title":"Nature Medicine"},{"key":"11040_CR41","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biomaterials.2018.03.033","volume":"196","author":"E G\u00f3mez-Barrena","year":"2019","unstructured":"G\u00f3mez-Barrena, E., Rosset, P., Gebhard, F., Hernigou, P., Baldini, N., Rouard, H., Senseb\u00e9, L., et al. (2019). Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial. Biomaterials, 196, 100\u2013108. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.03.033","journal-title":"Biomaterials"},{"key":"11040_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-019-1166-4","volume":"10","author":"JF Blanco","year":"2019","unstructured":"Blanco, J. F., Villar\u00f3n, E. M., Pescador, D., da Casa, C., G\u00f3mez, V., Redondo, A. M., L\u00f3pez-Villar, O., et al. (2019). Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I\/II clinical trial with long-term follow-up. Stem Cell Research & Therapy, 10, 63. https:\/\/doi.org\/10.1186\/s13287-019-1166-4","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR43","doi-asserted-by":"publisher","first-page":"111596","DOI":"10.1016\/j.injury.2024.111596","volume":"55","author":"D Chaverri","year":"2024","unstructured":"Chaverri, D., Gallardo-Villares, S., Pinto, J. A., Rodr\u00edguez, L., Codinach, M., Garc\u00eda-L\u00f3pez, J., Querol, S., et al. (2024). Treatment of non-hypertrophic pseudoarthrosis of long bones with a tissue engineered product loaded with autologous bone marrow-derived mesenchymal stromal cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to Iliac crest autograft. Injury, 55, 111596. https:\/\/doi.org\/10.1016\/j.injury.2024.111596","journal-title":"Injury"},{"key":"11040_CR44","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bbrc.2004.06.029","volume":"320","author":"N Indrawattana","year":"2004","unstructured":"Indrawattana, N., Chen, G., Tadokoro, M., Shann, L. H., Ohgushi, H., Tateishi, T., Tanaka, J., et al. (2004). Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochemical and Biophysical Research Communications, 320, 914\u2013919. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.029","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"11040_CR45","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.joca.2015.06.019","volume":"23","author":"JJ Cherian","year":"2015","unstructured":"Cherian, J. J., Parvizi, J., Bramlet, D., Lee, K. H., Romness, D. W., & Mont, M. A. (2015). Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-\u03b21 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage, 23, 2109\u20132118. https:\/\/doi.org\/10.1016\/j.joca.2015.06.019","journal-title":"Osteoarthritis Cartilage"},{"key":"11040_CR46","doi-asserted-by":"publisher","unstructured":"Lee, M. C., Ha, C. W., Elmallah, R. K., Cherian, J. J., Cho, J. J., Kim, T. W., Bin, S. I., et al. (2015). A placebo-controlled randomised trial to assess the effect of TGF-\u00df1-expressing chondrocytes in patients with arthritis of the knee. Bone Joint J, 97. https:\/\/doi.org\/10.1302\/0301-620x.97b7.35852. -b:924\u2009\u2013\u200932.","DOI":"10.1302\/0301-620x.97b7.35852"},{"key":"11040_CR47","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1038\/s41598-023-42349-x","volume":"13","author":"X Pan","year":"2023","unstructured":"Pan, X., Li, X., Zhang, L., Wu, F., Zhang, Q., Xu, S., Shen, C., et al. (2023). Umbilical cord mesenchymal stem cells relieve osteoarthritis in rats through immunoregulation and Inhibition of chondrocyte apoptosis. Scientific Reports, 13, 14975. https:\/\/doi.org\/10.1038\/s41598-023-42349-x","journal-title":"Scientific Reports"},{"key":"11040_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5966\/sctm.2016-0157","volume":"6","author":"YB Park","year":"2017","unstructured":"Park, Y. B., Ha, C. W., Lee, C. H., Yoon, Y. C., & Park, Y. G. (2017). Cartilage regeneration in Osteoarthritic patients by a composite of allogeneic umbilical cord Blood-Derived mesenchymal stem cells and hyaluronate hydrogel: Results from a clinical trial for safety and Proof-of-Concept with 7 years of extended Follow-Up. Stem Cells Transl Med, 6, 613\u2013621. https:\/\/doi.org\/10.5966\/sctm.2016-0157","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.reth.2019.10.003","volume":"14","author":"JS Song","year":"2020","unstructured":"Song, J. S., Hong, K. T., Kim, N. M., Jung, J. Y., Park, H. S., Lee, S. H., Cho, Y. J., et al. (2020). Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: Two-year follow-up. Regen Ther, 14, 32\u201339. https:\/\/doi.org\/10.1016\/j.reth.2019.10.003","journal-title":"Regen Ther"},{"key":"11040_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/stcltm\/szad088","volume":"13","author":"J Matas","year":"2024","unstructured":"Matas, J., Garc\u00eda, C., Poblete, D., Vernal, R., Ortloff, A., Luque-Campos, N., Hidalgo, Y., et al. (2024). A phase I Dose-Escalation clinical trial to assess the safety and efficacy of umbilical Cord-Derived mesenchymal stromal cells in knee osteoarthritis. Stem Cells Transl Med, 13, 193\u2013203. https:\/\/doi.org\/10.1093\/stcltm\/szad088","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12967-018-1591-7","volume":"16","author":"JM Lamo-Espinosa","year":"2018","unstructured":"Lamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Molt\u00f3, F., N\u00fa\u00f1ez-C\u00f3rdoba, J. M., L\u00f3pez-El\u00edo, S., Andreu, E., et al. (2018). Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Long-term follow up of a multicenter randomized controlled clinical trial (phase I\/II). J Transl Med, 16, 213. https:\/\/doi.org\/10.1186\/s12967-018-1591-7","journal-title":"J Transl Med"},{"key":"11040_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-020-02530-6","volume":"18","author":"JM Lamo-Espinosa","year":"2020","unstructured":"Lamo-Espinosa, J. M., Blanco, J. F., S\u00e1nchez, M., Moreno, V., Granero-Molt\u00f3, F., S\u00e1nchez-Guijo, F., Crespo-Cullel, \u00cd., et al. (2020). Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. J Transl Med, 18, 356. https:\/\/doi.org\/10.1186\/s12967-020-02530-6","journal-title":"J Transl Med"},{"key":"11040_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2217\/rme-2023-0222","volume":"19","author":"Z Yuan","year":"2024","unstructured":"Yuan, Z., Yu, D., Wang, Y., Liu, L., Wang, J., Ma, C., & Wu, S. (2024). Early delivery of human umbilical cord mesenchymal stem cells improves healing in a rat model of Achilles tendinopathy. Regenerative Medicine, 19, 93\u2013102. https:\/\/doi.org\/10.2217\/rme-2023-0222","journal-title":"Regenerative Medicine"},{"key":"11040_CR54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/stem.2855","volume":"36","author":"CH Jo","year":"2018","unstructured":"Jo, C. H., Chai, J. W., Jeong, E. C., Oh, S., Kim, P. S., Yoon, J. Y., & Yoon, K. S. (2018). Intratendinous injection of autologous adipose Tissue-Derived mesenchymal stem cells for the treatment of rotator cuff disease: A First-In-Human trial. Stem Cells, 36, 1441\u20131450. https:\/\/doi.org\/10.1002\/stem.2855","journal-title":"Stem Cells"},{"key":"11040_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/03635465231192473","volume":"52","author":"PA Nelson","year":"2024","unstructured":"Nelson, P. A., George, T., Bowen, E., Sheean, A. J., & Bedi, A. (2024). An update on orthobiologics: Cautious optimism. American Journal of Sports Medicine, 52, 242\u2013257. https:\/\/doi.org\/10.1177\/03635465231192473","journal-title":"American Journal of Sports Medicine"},{"key":"11040_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13770-023-00525-0","volume":"20","author":"S Moon","year":"2023","unstructured":"Moon, S., Hong, J., Go, S., & Kim, B. S. (2023). Immunomodulation for tissue repair and regeneration. Tissue Eng Regen Med, 20, 389\u2013409. https:\/\/doi.org\/10.1007\/s13770-023-00525-0","journal-title":"Tissue Eng Regen Med"},{"key":"11040_CR57","doi-asserted-by":"publisher","unstructured":"Caplan, A. I., & Correa, D. (2011). The MSC: An injury drugstore. Cell Stem Cell, 9. https:\/\/doi.org\/10.1016\/j.stem.2011.06.008. :11\u2009\u2013\u20095.","DOI":"10.1016\/j.stem.2011.06.008"},{"key":"11040_CR58","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan, X. L., Zhang, Y., Li, X., & Fu, Q. L. (2020). Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cellular and Molecular Life Sciences, 77, 2771\u20132794. https:\/\/doi.org\/10.1007\/s00018-020-03454-6","journal-title":"Cellular and Molecular Life Sciences"},{"key":"11040_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.18632\/oncotarget.28672","volume":"15","author":"T Minev","year":"2024","unstructured":"Minev, T., Balbuena, S., Gill, J. M., Marincola, F. M., Kesari, S., & Lin, F. (2024). Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget, 15, 793\u2013805. https:\/\/doi.org\/10.18632\/oncotarget.28672","journal-title":"Oncotarget"},{"key":"11040_CR60","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel, R., Zibert, A., Laryea, M., G\u00f6bel, U., D\u00e4ubener, W., & Dilloo, D. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated Tryptophan degradation. Blood, 103, 4619\u20134621. https:\/\/doi.org\/10.1182\/blood-2003-11-3909","journal-title":"Blood"},{"key":"11040_CR61","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13287-019-1488-2","volume":"10","author":"Z Lu","year":"2019","unstructured":"Lu, Z., Chang, W., Meng, S., Xu, X., Xie, J., Guo, F., Yang, Y., et al. (2019). Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Stem Cell Research & Therapy, 10, 372. https:\/\/doi.org\/10.1186\/s13287-019-1488-2","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR62","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12015-013-9455-2","volume":"9","author":"MH Abumaree","year":"2013","unstructured":"Abumaree, M. H., Al Jumah, M. A., Kalionis, B., Jawdat, D., Al Khaldi, A., Abomaray, F. M., Fatani, A. S., et al. (2013). Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages. Stem Cell Rev Rep, 9, 620\u2013641. https:\/\/doi.org\/10.1007\/s12015-013-9455-2","journal-title":"Stem Cell Rev Rep"},{"key":"11040_CR63","doi-asserted-by":"publisher","unstructured":"Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019). Mesenchymal stem Cell-Derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells, 8. https:\/\/doi.org\/10.3390\/cells8121605","DOI":"10.3390\/cells8121605"},{"key":"11040_CR64","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1080\/15384101.2018.1526603","volume":"17","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Lin, L., Zou, R., Wen, C., Wang, Z., & Lin, F. (2018). MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1\/miR-206\/GIT1 axis in osteoarthritis. Cell Cycle, 17, 2411\u20132422. https:\/\/doi.org\/10.1080\/15384101.2018.1526603","journal-title":"Cell Cycle"},{"key":"11040_CR65","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/sctm.19-0114","volume":"9","author":"D Allan","year":"2020","unstructured":"Allan, D., Tieu, A., Lalu, M., & Burger, D. (2020). Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application. Stem Cells Transl Med, 9, 39\u201346. https:\/\/doi.org\/10.1002\/sctm.19-0114","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.imlet.2012.06.001","volume":"147","author":"A Mokarizadeh","year":"2012","unstructured":"Mokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A. A., & Mardani, K. (2012). Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling. Immunology Letters, 147, 47\u201354. https:\/\/doi.org\/10.1016\/j.imlet.2012.06.001","journal-title":"Immunology Letters"},{"key":"11040_CR67","doi-asserted-by":"publisher","unstructured":"Clark, K., Zhang, S., Barthe, S., Kumar, P., Pivetti, C., Kreutzberg, N., Reed, C., et al. (2019). Placental mesenchymal stem Cell-Derived extracellular vesicles promote Myelin regeneration in an animal model of multiple sclerosis. Cells, 8. https:\/\/doi.org\/10.3390\/cells8121497","DOI":"10.3390\/cells8121497"},{"key":"11040_CR68","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4103\/1673-5374.255978","volume":"14","author":"EE Reza-Zaldivar","year":"2019","unstructured":"Reza-Zaldivar, E. E., Hern\u00e1ndez-Sapi\u00e9ns, M. A., Guti\u00e9rrez-Mercado, Y. K., Sandoval-\u00c1vila, S., Gomez-Pinedo, U., M\u00e1rquez-Aguirre, A. L., V\u00e1zquez-M\u00e9ndez, E., et al. (2019). Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of alzheimer\u2019s disease. Neural Regen Res, 14, 1626\u20131634. https:\/\/doi.org\/10.4103\/1673-5374.255978","journal-title":"Neural Regen Res"},{"key":"11040_CR69","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau, J., & Sens\u00e9b\u00e9, L. (2018). Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell, 22, 824\u2013833. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004","journal-title":"Cell Stem Cell"},{"key":"11040_CR70","doi-asserted-by":"publisher","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","volume":"6","author":"O Levy","year":"2020","unstructured":"Levy, O., Kuai, R., Siren, E. M. J., Bhere, D., Milton, Y., Nissar, N., De Biasio, M., et al. (2020). Shattering barriers toward clinically meaningful MSC therapies. Science Advances, 6, eaba6884. https:\/\/doi.org\/10.1126\/sciadv.aba6884","journal-title":"Science Advances"},{"key":"11040_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1574888x16666201221151853","volume":"17","author":"M Rasouli","year":"2022","unstructured":"Rasouli, M., Vakilian, F., & Ranjbari, J. (2022). Therapeutic and protective potential of mesenchymal stem Cells, pharmaceutical agents and current vaccines against COVID-19. Curr Stem Cell Res Ther, 17, 166\u2013185. https:\/\/doi.org\/10.2174\/1574888x16666201221151853","journal-title":"Curr Stem Cell Res Ther"},{"key":"11040_CR72","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10529-020-02831-2","volume":"42","author":"R Zhang","year":"2020","unstructured":"Zhang, R., Zhu, Y., Li, Y., Liu, W., Yin, L., Yin, S., Ji, C., et al. (2020). Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotechnology Letters, 42, 669\u2013679. https:\/\/doi.org\/10.1007\/s10529-020-02831-2","journal-title":"Biotechnology Letters"},{"key":"11040_CR73","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ymthe.2020.04.020","volume":"28","author":"H Kim","year":"2020","unstructured":"Kim, H., Lee, M. J., Bae, E. H., Ryu, J. S., Kaur, G., Kim, H. J., Kim, J. Y., et al. (2020). Comprehensive molecular profiles of functionally effective MSC-Derived extracellular vesicles in Immunomodulation. Molecular Therapy, 28, 1628\u20131644. https:\/\/doi.org\/10.1016\/j.ymthe.2020.04.020","journal-title":"Molecular Therapy"},{"key":"11040_CR74","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00125-014-3262-4","volume":"57","author":"E Favaro","year":"2014","unstructured":"Favaro, E., Carpanetto, A., Lamorte, S., Fusco, A., Caorsi, C., Deregibus, M. C., Bruno, S., et al. (2014). Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes. Diabetologia, 57, 1664\u20131673. https:\/\/doi.org\/10.1007\/s00125-014-3262-4","journal-title":"Diabetologia"},{"key":"11040_CR75","doi-asserted-by":"publisher","first-page":"105689","DOI":"10.1016\/j.intimp.2019.105689","volume":"74","author":"M Mahmoudi","year":"2019","unstructured":"Mahmoudi, M., Taghavi-Farahabadi, M., Rezaei, N., & Hashemi, S. M. (2019). Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis. International Immunopharmacology, 74, 105689. https:\/\/doi.org\/10.1016\/j.intimp.2019.105689","journal-title":"International Immunopharmacology"},{"key":"11040_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40364-019-0156-0","volume":"7","author":"P Lai","year":"2019","unstructured":"Lai, P., Weng, J., Guo, L., Chen, X., & Du, X. (2019). Novel insights into MSC-EVs therapy for immune diseases. Biomarker Research, 7, 6. https:\/\/doi.org\/10.1186\/s40364-019-0156-0","journal-title":"Biomarker Research"},{"key":"11040_CR77","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1089\/scd.2014.0091","volume":"23","author":"A Conforti","year":"2014","unstructured":"Conforti, A., Scarsella, M., Starc, N., Giorda, E., Biagini, S., Proia, A., Carsetti, R., et al. (2014). Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells and Development, 23, 2591\u20132599. https:\/\/doi.org\/10.1089\/scd.2014.0091","journal-title":"Stem Cells and Development"},{"key":"11040_CR78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrneph.2011.16","volume":"7","author":"AA Sharfuddin","year":"2011","unstructured":"Sharfuddin, A. A., & Molitoris, B. A. (2011). Pathophysiology of ischemic acute kidney injury. Nature Reviews Nephrology, 7, 189\u2013200. https:\/\/doi.org\/10.1038\/nrneph.2011.16","journal-title":"Nature Reviews Nephrology"},{"key":"11040_CR79","doi-asserted-by":"publisher","first-page":"143463","DOI":"10.1155\/2014\/143463","volume":"2014","author":"H Thomas","year":"2014","unstructured":"Thomas, H., J\u00e4ger, M., Mauel, K., Brandau, S., Lask, S., & Floh\u00e9, S. B. (2014). Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12\/IL-18-induced interferon-gamma secretion. Mediators Inflamm, 2014, 143463. https:\/\/doi.org\/10.1155\/2014\/143463","journal-title":"Mediators Inflamm"},{"key":"11040_CR80","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies, L. C., Heldring, N., Kadri, N., & Le Blanc, K. (2017). Mesenchymal stromal cell secretion of programmed Death-1 ligands regulates T cell mediated immunosuppression. Stem Cells, 35, 766\u2013776. https:\/\/doi.org\/10.1002\/stem.2509","journal-title":"Stem Cells"},{"key":"11040_CR81","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/stemcells.2007-0454","volume":"26","author":"F Liotta","year":"2008","unstructured":"Liotta, F., Angeli, R., Cosmi, L., Fil\u00ec, L., Manuelli, C., Frosali, F., Mazzinghi, B., et al. (2008). Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells, 26, 279\u2013289. https:\/\/doi.org\/10.1634\/stemcells.2007-0454","journal-title":"Stem Cells"},{"key":"11040_CR82","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K., Chen, C., Wang, D., Xu, X., Qu, C., Yamaza, T., Cai, T., et al. (2012). Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell, 10, 544\u2013555. https:\/\/doi.org\/10.1016\/j.stem.2012.03.007","journal-title":"Cell Stem Cell"},{"key":"11040_CR83","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3324\/haematol.12857","volume":"93","author":"S Tabera","year":"2008","unstructured":"Tabera, S., P\u00e9rez-Sim\u00f3n, J. A., D\u00edez-Campelo, M., S\u00e1nchez-Abarca, L. I., Blanco, B., L\u00f3pez, A., Benito, A., et al. (2008). The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica, 93, 1301\u20131309. https:\/\/doi.org\/10.3324\/haematol.12857","journal-title":"Haematologica"},{"key":"11040_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.imlet.2020.03.005","volume":"222","author":"X Li","year":"2020","unstructured":"Li, X., Dong, Y., Yin, H., Qi, Z., Wang, D., & Ren, S. (2020). Mesenchymal stem cells induced regulatory dendritic cells from Hemopoietic progenitor cells through Notch pathway and TGF-\u03b2 synergistically. Immunology Letters, 222, 49\u201357. https:\/\/doi.org\/10.1016\/j.imlet.2020.03.005","journal-title":"Immunology Letters"},{"key":"11040_CR85","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.2417","volume":"34","author":"D Jiang","year":"2016","unstructured":"Jiang, D., Muschhammer, J., Qi, Y., K\u00fcgler, A., de Vries, J. C., Saffarzadeh, M., Sindrilaru, A., et al. (2016). Suppression of Neutrophil-Mediated tissue Damage-A novel skill of mesenchymal stem cells. Stem Cells, 34, 2393\u20132406. https:\/\/doi.org\/10.1002\/stem.2417","journal-title":"Stem Cells"},{"key":"11040_CR86","doi-asserted-by":"publisher","first-page":"1000166","DOI":"10.4172\/2157-7633.1000166","volume":"4","author":"ME Reinders","year":"2014","unstructured":"Reinders, M. E., & Hoogduijn, M. J. (2014). NK cells and mscs: Possible implications for MSC therapy in renal transplantation. J Stem Cell Res Ther, 4, 1000166. https:\/\/doi.org\/10.4172\/2157-7633.1000166","journal-title":"J Stem Cell Res Ther"},{"key":"11040_CR87","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/stem.1563","volume":"32","author":"M Giuliani","year":"2014","unstructured":"Giuliani, M., Bennaceur-Griscelli, A., Nanbakhsh, A., Oudrhiri, N., Chouaib, S., Azzarone, B., Durrbach, A., et al. (2014). TLR ligands stimulation protects MSC from NK killing. Stem Cells, 32, 290\u2013300. https:\/\/doi.org\/10.1002\/stem.1563","journal-title":"Stem Cells"},{"key":"11040_CR88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cellimm.2011.06.014","volume":"271","author":"J Lei","year":"2011","unstructured":"Lei, J., Wang, Z., Hui, D., Yu, W., Zhou, D., Xia, W., Chen, C., et al. (2011). Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cellular Immunology, 271, 147\u2013156. https:\/\/doi.org\/10.1016\/j.cellimm.2011.06.014","journal-title":"Cellular Immunology"},{"key":"11040_CR89","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-019-0204-6","volume":"16","author":"Y Li","year":"2019","unstructured":"Li, Y., Zhang, D., Xu, L., Dong, L., Zheng, J., Lin, Y., Huang, J., et al. (2019). Cell-cell contact with Proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models. Cellular & Molecular Immunology, 16, 908\u2013920. https:\/\/doi.org\/10.1038\/s41423-019-0204-6","journal-title":"Cellular & Molecular Immunology"},{"key":"11040_CR90","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/s0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. Lancet, 389, 2239\u20132251. https:\/\/doi.org\/10.1016\/s0140-6736(17)30058-2","journal-title":"Lancet"},{"key":"11040_CR91","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","volume":"13","author":"H Jiao","year":"2015","unstructured":"Jiao, H., Xiao, E., & Graves, D. T. (2015). Diabetes and its effect on bone and fracture healing. Current Osteoporosis Reports, 13, 327\u2013335. https:\/\/doi.org\/10.1007\/s11914-015-0286-8","journal-title":"Current Osteoporosis Reports"},{"key":"11040_CR92","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2741\/2757","volume":"13","author":"DT Graves","year":"2008","unstructured":"Graves, D. T., & Kayal, R. A. (2008). Diabetic complications and dysregulated innate immunity. Frontiers in Bioscience : A Journal and Virtual Library, 13, 1227\u20131239. https:\/\/doi.org\/10.2741\/2757","journal-title":"Frontiers in Bioscience : A Journal and Virtual Library"},{"key":"11040_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/gene.2011.14","volume":"12","author":"BS Nikolajczyk","year":"2011","unstructured":"Nikolajczyk, B. S., Jagannathan-Bogdan, M., Shin, H., & Gyurko, R. (2011). State of the union between metabolism and the immune system in type 2 diabetes. Genes and Immunity, 12, 239\u2013250. https:\/\/doi.org\/10.1038\/gene.2011.14","journal-title":"Genes and Immunity"},{"key":"11040_CR94","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1177\/0022034512465292","volume":"91","author":"OM Andriankaja","year":"2012","unstructured":"Andriankaja, O. M., Galicia, J., Dong, G., Xiao, W., Alawi, F., & Graves, D. T. (2012). Gene expression dynamics during diabetic periodontitis. Journal of Dental Research, 91, 1160\u20131165. https:\/\/doi.org\/10.1177\/0022034512465292","journal-title":"Journal of Dental Research"},{"key":"11040_CR95","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1096\/fj.11-196279","volume":"26","author":"S Pacios","year":"2012","unstructured":"Pacios, S., Kang, J., Galicia, J., Gluck, K., Patel, H., Ovaydi-Mandel, A., Petrov, S., et al. (2012). Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. Faseb J, 26, 1423\u20131430. https:\/\/doi.org\/10.1096\/fj.11-196279","journal-title":"Faseb J"},{"key":"11040_CR96","doi-asserted-by":"publisher","first-page":"1216321","DOI":"10.3389\/fimmu.2023.1216321","volume":"14","author":"S Nirenjen","year":"2023","unstructured":"Nirenjen, S., Narayanan, J., Tamilanban, T., Subramaniyan, V., Chitra, V., Fuloria, N. K., Wong, L. S., et al. (2023). Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes. Frontiers in Immunology, 14, 1216321. https:\/\/doi.org\/10.3389\/fimmu.2023.1216321","journal-title":"Frontiers in Immunology"},{"key":"11040_CR97","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcte.2014.10.002","volume":"1","author":"Y Thewjitcharoen","year":"2014","unstructured":"Thewjitcharoen, Y., Krittiyawong, S., Porramatikul, S., Parksook, W., Chatapat, L., Watchareejirachot, O., Sripatpong, J., et al. (2014). Outcomes of hospitalized diabetic foot patients in a multi-disciplinary team setting: Thailand\u2019s experience. J Clin Transl Endocrinol, 1, 187\u2013191. https:\/\/doi.org\/10.1016\/j.jcte.2014.10.002","journal-title":"J Clin Transl Endocrinol"},{"key":"11040_CR98","doi-asserted-by":"publisher","first-page":"1099310","DOI":"10.3389\/fendo.2023.1099310","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu, X., Liu, P., Li, Z., & Zhang, Z. (2023). Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds. Front Endocrinol (Lausanne), 14, 1099310. https:\/\/doi.org\/10.3389\/fendo.2023.1099310","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11040_CR99","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bone.2012.12.006","volume":"53","author":"J Alblowi","year":"2013","unstructured":"Alblowi, J., Tian, C., Siqueira, M. F., Kayal, R. A., McKenzie, E., Behl, Y., Gerstenfeld, L., et al. (2013). Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone, 53, 294\u2013300. https:\/\/doi.org\/10.1016\/j.bone.2012.12.006","journal-title":"Bone"},{"key":"11040_CR100","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ajpath.2013.08.017","volume":"183","author":"S Pacios","year":"2013","unstructured":"Pacios, S., Andriankaja, O., Kang, J., Alnammary, M., Bae, J., de Brito Bezerra, B., Schreiner, H., et al. (2013). Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis. American Journal of Pathology, 183, 1928\u20131935. https:\/\/doi.org\/10.1016\/j.ajpath.2013.08.017","journal-title":"American Journal of Pathology"},{"key":"11040_CR101","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.2174\/138945011798829456","volume":"12","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi, S. (2011). Role of advanced glycation end products (AGEs) in osteoporosis in diabetes. Current Drug Targets, 12, 2096\u20132102. https:\/\/doi.org\/10.2174\/138945011798829456","journal-title":"Current Drug Targets"},{"key":"11040_CR102","unstructured":"Sarkar, P. D., & Choudhury, A. B. (2013). Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci 17:1631-5. PMID: 23832730."},{"key":"11040_CR103","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bone.2010.12.016","volume":"48","author":"JS Nyman","year":"2011","unstructured":"Nyman, J. S., Even, J. L., Jo, C. H., Herbert, E. G., Murry, M. R., Cockrell, G. E., Wahl, E. C., et al. (2011). Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone, 48, 733\u2013740. https:\/\/doi.org\/10.1016\/j.bone.2010.12.016","journal-title":"Bone"},{"key":"11040_CR104","doi-asserted-by":"publisher","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill, K. M., LumpkinJr., C. K., Bunn, R. C., Kemp, S. F., & Fowlkes, J. L. (2005). Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. American Journal of Physiology. Endocrinology and Metabolism, 289, E735\u2013E745. https:\/\/doi.org\/10.1152\/ajpendo.00159.2005","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"11040_CR105","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2337\/dc06-0440","volume":"29","author":"M Janghorbani","year":"2006","unstructured":"Janghorbani, M., Feskanich, D., Willett, W. C., & Hu, F. (2006). Prospective study of diabetes and risk of hip fracture: The nurses\u2019 health study. Diabetes Care, 29, 1573\u20131578. https:\/\/doi.org\/10.2337\/dc06-0440","journal-title":"Diabetes Care"},{"key":"11040_CR106","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani, M., Van Dam, R. M., Willett, W. C., & Hu, F. B. (2007). Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. American Journal of Epidemiology, 166, 495\u2013505. https:\/\/doi.org\/10.1093\/aje\/kwm106","journal-title":"American Journal of Epidemiology"},{"key":"11040_CR107","doi-asserted-by":"publisher","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","volume":"5","author":"C Bouffi","year":"2010","unstructured":"Bouffi, C., Bony, C., Courties, G., Jorgensen, C., & No\u00ebl, D. (2010). IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One, 5, e14247. https:\/\/doi.org\/10.1371\/journal.pone.0014247","journal-title":"PLoS One"},{"key":"11040_CR108","doi-asserted-by":"publisher","first-page":"9328347","DOI":"10.1155\/2017\/9328347","volume":"2017","author":"Y Cao","year":"2017","unstructured":"Cao, Y., Gang, X., Sun, C., & Wang, G. (2017). Mesenchymal stem cells improve healing of diabetic foot ulcer. Journal of Diabetes Research, 2017, 9328347. https:\/\/doi.org\/10.1155\/2017\/9328347","journal-title":"Journal of Diabetes Research"},{"key":"11040_CR109","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00125-014-3470-y","volume":"58","author":"KI Ko","year":"2015","unstructured":"Ko, K. I., Coimbra, L. S., Tian, C., Alblowi, J., Kayal, R. A., Einhorn, T. A., Gerstenfeld, L. C., et al. (2015). Diabetes reduces mesenchymal stem cells in fracture healing through a TNF\u03b1-mediated mechanism. Diabetologia, 58, 633\u2013642. https:\/\/doi.org\/10.1007\/s00125-014-3470-y","journal-title":"Diabetologia"},{"key":"11040_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12079-021-00635-1","volume":"16","author":"S Thomas","year":"2022","unstructured":"Thomas, S., & Jaganathan, B. G. (2022). Signaling network regulating osteogenesis in mesenchymal stem cells. J Cell Commun Signal, 16, 47\u201361. https:\/\/doi.org\/10.1007\/s12079-021-00635-1","journal-title":"J Cell Commun Signal"},{"key":"11040_CR111","doi-asserted-by":"publisher","first-page":"1150068","DOI":"10.3389\/fendo.2023.1150068","volume":"14","author":"M Luo","year":"2023","unstructured":"Luo, M., Zhao, Z., & Yi, J. (2023). Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia. Front Endocrinol (Lausanne), 14, 1150068. https:\/\/doi.org\/10.3389\/fendo.2023.1150068","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11040_CR112","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.actbio.2024.11.040","volume":"192","author":"D Avery","year":"2025","unstructured":"Avery, D., Morandini, L., Sheakley, L., Alajmi, A., Bergey, L., Donahue, H. J., Martin, R. K., et al. (2025). Obesity prolongs the pro-inflammatory response and attenuates bone healing on titanium implants. Acta Biomaterialia, 192, 473\u2013486. https:\/\/doi.org\/10.1016\/j.actbio.2024.11.040","journal-title":"Acta Biomaterialia"},{"key":"11040_CR113","doi-asserted-by":"publisher","first-page":"117139","DOI":"10.1016\/j.biopha.2024.117139","volume":"177","author":"Y Guo","year":"2024","unstructured":"Guo, Y., Jiang, S., Li, H., Xie, G., Pavel, V., Zhang, Q., Li, Y., et al. (2024). Obesity induces osteoimmunology imbalance: Molecular mechanisms and clinical implications. Biomedicine & Pharmacotherapy, 177, 117139. https:\/\/doi.org\/10.1016\/j.biopha.2024.117139","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11040_CR114","doi-asserted-by":"publisher","first-page":"9","DOI":"10.52312\/jdrs.2023.649","volume":"34","author":"SJJ Issace","year":"2023","unstructured":"Issace, S. J. J., Singh, R., Sisubalasingam, N., Tokg\u00f6z, M. A., Jaiman, A., & Rampal, S. (2023). Does obesity affect diaphyseal femoral fracture healing treated with intramedullary locking nail? Jt Dis Relat Surg, 34, 9\u201315. https:\/\/doi.org\/10.52312\/jdrs.2023.649","journal-title":"Jt Dis Relat Surg"},{"key":"11040_CR115","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/jcmm.16273","volume":"25","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Chen, W., Zhao, L., Li, Y., Liu, Z., Gao, H., Bai, X., et al. (2021). Obesity regulates miR-467\/HoxA10 axis on osteogenic differentiation and fracture healing by BMSC-derived exosome LncRNA H19. Journal of Cellular and Molecular Medicine, 25, 1712\u20131724. https:\/\/doi.org\/10.1111\/jcmm.16273","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"11040_CR116","doi-asserted-by":"publisher","unstructured":"Tarantino, U., Cariati, I., Greggi, C., Gasbarra, E., Belluati, A., Ciolli, L., Maccauro, G., et al. (2021). Skeletal system biology and smoke damage: From basic science to medical clinic. International Journal of Molecular Sciences, 22. https:\/\/doi.org\/10.3390\/ijms22126629","DOI":"10.3390\/ijms22126629"},{"key":"11040_CR117","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jbmr.4014","volume":"35","author":"H Li","year":"2020","unstructured":"Li, H., Wallin, M., Barregard, L., Sallsten, G., Lundh, T., Ohlsson, C., Mellstr\u00f6m, D., et al. (2020). Smoking-Induced risk of osteoporosis is partly mediated by cadmium from tobacco smoke: The MrOS Sweden study. Journal of Bone and Mineral Research, 35, 1424\u20131429. https:\/\/doi.org\/10.1002\/jbmr.4014","journal-title":"Journal of Bone and Mineral Research"},{"key":"11040_CR118","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0020-1383(00)00121-2","volume":"32","author":"CI Adams","year":"2001","unstructured":"Adams, C. I., Keating, J. F., & Court-Brown, C. M. (2001). Cigarette smoking and open tibial fractures. Injury, 32, 61\u201365. https:\/\/doi.org\/10.1016\/s0020-1383(00)00121-2","journal-title":"Injury"},{"key":"11040_CR119","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/sctm.17-0060","volume":"6","author":"JM Greenberg","year":"2017","unstructured":"Greenberg, J. M., Carballosa, C. M., & Cheung, H. S. (2017). Concise review: The deleterious effects of cigarette smoking and nicotine usage and mesenchymal stem cell function and implications for cell-Based therapies. Stem Cells Transl Med, 6, 1815\u20131821. https:\/\/doi.org\/10.1002\/sctm.17-0060","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR120","doi-asserted-by":"publisher","unstructured":"Aspera-Werz, R. H., Chen, T., Ehnert, S., Zhu, S., Fr\u00f6hlich, T., & Nussler, A. K. (2019). Cigarette smoke induces the risk of metabolic bone diseases: Transforming growth factor beta signaling impairment via dysfunctional primary cilia affects Migration, Proliferation, and differentiation of human mesenchymal stem cells. International Journal of Molecular Sciences, 20. https:\/\/doi.org\/10.3390\/ijms20122915","DOI":"10.3390\/ijms20122915"},{"key":"11040_CR121","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., et al. (2000). Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. Journal of Experimental Medicine, 191, 275\u2013286. https:\/\/doi.org\/10.1084\/jem.191.2.275","journal-title":"Journal of Experimental Medicine"},{"key":"11040_CR122","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","volume":"21","author":"HM Torres","year":"2023","unstructured":"Torres, H. M., Arnold, K. M., Oviedo, M., Westendorf, J. J., & Weaver, S. R. (2023). Inflammatory processes affecting bone health and repair. Current Osteoporosis Reports, 21, 842\u2013853. https:\/\/doi.org\/10.1007\/s11914-023-00824-4","journal-title":"Current Osteoporosis Reports"},{"key":"11040_CR123","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1038\/s41467-022-31475-1","volume":"13","author":"Y Xia","year":"2022","unstructured":"Xia, Y., Inoue, K., Du, Y., Baker, S. J., Reddy, E. P., Greenblatt, M. B., & Zhao, B. (2022). TGF\u03b2 reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nature Communications, 13, 3920. https:\/\/doi.org\/10.1038\/s41467-022-31475-1","journal-title":"Nature Communications"},{"key":"11040_CR124","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/shk.0000000000000692","volume":"46","author":"JS VanEpps","year":"2016","unstructured":"VanEpps, J. S., & Younger, J. G. (2016). Implantable Device-Related Infection Shock 46:597\u2013608. https:\/\/doi.org\/10.1097\/shk.0000000000000692.","journal-title":"Implantable Device-Related Infection Shock"},{"key":"11040_CR125","doi-asserted-by":"publisher","first-page":"77","DOI":"10.22203\/eCM.v039a05","volume":"39","author":"SM Shiels","year":"2020","unstructured":"Shiels, S. M., Mangum, L. H., & Wenke, J. C. (2020). Revisiting the race for the surface in a pre-clinical model of implant infection. Eur Cell Mater, 39, 77\u201395. https:\/\/doi.org\/10.22203\/eCM.v039a05","journal-title":"Eur Cell Mater"},{"key":"11040_CR126","doi-asserted-by":"publisher","first-page":"106527","DOI":"10.1016\/j.jddst.2024.106527","volume":"104","author":"A Efendi","year":"2025","unstructured":"Efendi, A., Naknaen, A., Ampawa, S., Miengmern, N., Chaikeeratisak, V., & Wanichwecharungruang, S. (2025). Detachable dissolvable microneedles maintain the viability of phage cocktail and effectively disrupt Pseudomonas aeruginosa biofilm. Journal of Drug Delivery Science and Technology, 104, 106527. https:\/\/doi.org\/10.1016\/j.jddst.2024.106527","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"11040_CR127","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/jor.25261","volume":"40","author":"JE Hellwinkel","year":"2022","unstructured":"Hellwinkel, J. E., Working, Z. M., Certain, L., Garc\u00eda, A. J., Wenke, J. C., & Bahney, C. S. (2022). The intersection of fracture healing and infection: Orthopaedics research society workshop 2021. Journal of Orthopaedic Research, 40, 541\u2013552. https:\/\/doi.org\/10.1002\/jor.25261","journal-title":"Journal of Orthopaedic Research"},{"key":"11040_CR128","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4252\/wjsc.v13.i6.568","volume":"13","author":"A Sharma","year":"2021","unstructured":"Sharma, A., Chakraborty, A., & Jaganathan, B. G. (2021). Review of the potential of mesenchymal stem cells for the treatment of infectious diseases. World J Stem Cells, 13, 568\u2013593. https:\/\/doi.org\/10.4252\/wjsc.v13.i6.568","journal-title":"World J Stem Cells"},{"key":"11040_CR129","doi-asserted-by":"publisher","first-page":"e0006421","DOI":"10.1128\/cmr.00064-21","volume":"34","author":"TD Shaw","year":"2021","unstructured":"Shaw, T. D., Krasnodembskaya, A. D., Schroeder, G. N., Zumla, A., Maeurer, M., & O\u2019Kane, C. M. (2021). Mesenchymal stromal cells: An antimicrobial And Host-Directed therapy for complex infectious diseases. Clinical Microbiology Reviews, 34, e0006421. https:\/\/doi.org\/10.1128\/cmr.00064-21","journal-title":"Clinical Microbiology Reviews"},{"key":"11040_CR130","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/sctm.19-0333","volume":"9","author":"C Marx","year":"2020","unstructured":"Marx, C., Gardner, S., & Harman, R. M. (2020). The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model. Stem Cells Transl Med, 9, 746\u2013757. https:\/\/doi.org\/10.1002\/sctm.19-0333. Van de.","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR131","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.stemcr.2017.06.020","volume":"9","author":"RM Petri","year":"2017","unstructured":"Petri, R. M., Hackel, A., Hahnel, K., Dumitru, C. A., Bruderek, K., Flohe, S. B., Paschen, A., et al. (2017). Activated Tissue-Resident mesenchymal stromal cells regulate natural killer cell immune and Tissue-Regenerative function. Stem Cell Reports, 9, 985\u2013998. https:\/\/doi.org\/10.1016\/j.stemcr.2017.06.020","journal-title":"Stem Cell Reports"},{"key":"11040_CR132","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/stem.1996","volume":"33","author":"YX Mao","year":"2015","unstructured":"Mao, Y. X., Xu, J. F., Seeley, E. J., Tang, X. D., Xu, L. L., Zhu, Y. G., Song, Y. L., et al. (2015). Adipose Tissue-Derived mesenchymal stem cells attenuate pulmonary infection caused by Pseudomonas aeruginosa via inhibiting overproduction of prostaglandin E2. Stem Cells, 33, 2331\u20132342. https:\/\/doi.org\/10.1002\/stem.1996","journal-title":"Stem Cells"},{"key":"11040_CR133","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tube.2016.09.005","volume":"101","author":"YS Schwartz","year":"2016","unstructured":"Schwartz, Y. S., Belogorodtsev, S. N., Filimonov, P. N., Cherednichenko, A. G., Pustylnikov, S. V., & Krasnov, V. A. (2016). BCG infection in mice is promoted by na\u00efve mesenchymal stromal cells (MSC) and suppressed by poly(A: U)-conditioned MSC. Tuberculosis (Edinb), 101, 130\u2013136. https:\/\/doi.org\/10.1016\/j.tube.2016.09.005","journal-title":"Tuberculosis (Edinb)"},{"key":"11040_CR134","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13287-024-03781-6","volume":"15","author":"ZX Liu","year":"2024","unstructured":"Liu, Z. X., Liu, G. Q., Lin, Z. X., Chen, Y. Q., Chen, P., Hu, Y. J., Yu, B., et al. (2024). Effects of Staphylococcus aureus on stem cells and potential targeted treatment of inflammatory disorders. Stem Cell Research & Therapy, 15, 187. https:\/\/doi.org\/10.1186\/s13287-024-03781-6","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR135","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1089\/ten.TEC.2012.0290","volume":"19","author":"NJ Willett","year":"2013","unstructured":"Willett, N. J., Li, M. T., Uhrig, B. A., Boerckel, J. D., Huebsch, N., Lundgren, T. L., Warren, G. L., et al. (2013). Attenuated human bone morphogenetic protein-2-mediated bone regeneration in a rat model of composite bone and muscle injury. Tissue Eng Part C Methods, 19, 316\u2013325. https:\/\/doi.org\/10.1089\/ten.TEC.2012.0290","journal-title":"Tissue Eng Part C Methods"},{"key":"11040_CR136","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s11999-017-5473-8","volume":"475","author":"K Bundkirchen","year":"2017","unstructured":"Bundkirchen, K., Macke, C., Reifenrath, J., Sch\u00e4ck, L. M., Noack, S., Relja, B., Naber, P., et al. (2017). Severe hemorrhagic shock leads to a delayed fracture healing and decreased bone callus strength in a mouse model. Clinical Orthopaedics and Related Research, 475, 2783\u20132794. https:\/\/doi.org\/10.1007\/s11999-017-5473-8","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"11040_CR137","doi-asserted-by":"publisher","first-page":"934773","DOI":"10.3389\/fsurg.2022.934773","volume":"9","author":"CE Vantucci","year":"2022","unstructured":"Vantucci, C. E., Guyer, T., Leguineche, K., Chatterjee, P., Lin, A., Nash, K. E., Hastings, M. A., et al. (2022). Systemic immune modulation alters local bone regeneration in a delayed treatment composite model of Non-Union extremity trauma. Front Surg, 9, 934773. https:\/\/doi.org\/10.3389\/fsurg.2022.934773","journal-title":"Front Surg"},{"key":"11040_CR138","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jbiosc.2021.02.007","volume":"131","author":"L Zhang","year":"2021","unstructured":"Zhang, L., Wang, Q., Su, H., & Cheng, J. (2021). Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts. Journal of Bioscience and Bioengineering, 131, 671\u2013678. https:\/\/doi.org\/10.1016\/j.jbiosc.2021.02.007","journal-title":"Journal of Bioscience and Bioengineering"},{"key":"11040_CR139","doi-asserted-by":"publisher","unstructured":"Russo, M., Lepre, C. C., Conza, G., Tangredi, N., D\u2019Amico, G., Braile, A., Moretti, A., et al. (2025). New insights on the MiRNA role in diabetic tendinopathy: Adipose-Derived mesenchymal stem cell conditioned medium as a potential innovative Epigenetic-Based therapy for tendon healing. Biomolecules, 15. https:\/\/doi.org\/10.3390\/biom15020264","DOI":"10.3390\/biom15020264"},{"key":"11040_CR140","doi-asserted-by":"publisher","first-page":"483","DOI":"10.14336\/ad.2018.0616","volume":"10","author":"NK Dubey","year":"2019","unstructured":"Dubey, N. K., Wei, H. J., Yu, S. H., Williams, D. F., Wang, J. R., Deng, Y. H., Tsai, F. C., et al. (2019). Adipose-derived stem cells attenuates diabetic osteoarthritis via Inhibition of Glycation-mediated inflammatory cascade. Aging Dis, 10, 483\u2013496. https:\/\/doi.org\/10.14336\/ad.2018.0616","journal-title":"Aging Dis"},{"key":"11040_CR141","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10565-024-09877-2","volume":"40","author":"C Xu","year":"2024","unstructured":"Xu, C., Wang, Z., Liu, Y., Duan, K., & Guan, J. (2024). Delivery of miR-15b-5p via magnetic nanoparticle-enhanced bone marrow mesenchymal stem cell-derived extracellular vesicles mitigates diabetic osteoporosis by targeting GFAP. Cell Biology and Toxicology, 40, 52. https:\/\/doi.org\/10.1007\/s10565-024-09877-2","journal-title":"Cell Biology and Toxicology"},{"key":"11040_CR142","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.dental.2022.06.019","volume":"38","author":"F Camacho-Alonso","year":"2022","unstructured":"Camacho-Alonso, F., Tudela-Mulero, M. R., Buend\u00eda, A. J., Navarro, J. A., P\u00e9rez-Say\u00e1ns, M., & Mercado-D\u00edaz, A. M. (2022). Bone regeneration in critical-sized mandibular symphysis defects using bioceramics with or without bone marrow mesenchymal stem cells in healthy, diabetic, osteoporotic, and diabetic-osteoporotic rats. Dental Materials, 38, 1283\u20131300. https:\/\/doi.org\/10.1016\/j.dental.2022.06.019","journal-title":"Dental Materials"},{"key":"11040_CR143","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fbioe.2020.00641","volume":"8","author":"SB Goodman","year":"2020","unstructured":"Goodman, S. B., & Lin, T. (2020). Modifying MSC phenotype to facilitate bone healing: Biological approaches. Frontiers in Bioengineering and Biotechnology, 8, 641. https:\/\/doi.org\/10.3389\/fbioe.2020.00641","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"11040_CR144","doi-asserted-by":"publisher","first-page":"1318256","DOI":"10.1155\/2016\/1318256","volume":"2016","author":"AP Bastidas-Coral","year":"2016","unstructured":"Bastidas-Coral, A. P., Bakker, A. D., Zandieh-Doulabi, B., Kleverlaan, C. J., Bravenboer, N., Forouzanfar, T., & Klein-Nulend, J. (2016). Cytokines TNF-\u03b1, IL-6, IL-17F, and IL-4 differentially affect osteogenic differentiation of human adipose stem cells. Stem Cells Int, 2016, 1318256. https:\/\/doi.org\/10.1155\/2016\/1318256","journal-title":"Stem Cells Int"},{"key":"11040_CR145","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000095511","volume":"183","author":"P Kasten","year":"2006","unstructured":"Kasten, P., Vogel, J., Luginb\u00fchl, R., Niemeyer, P., Weiss, S., Schneider, S., Kramer, M., et al. (2006). Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs, 183, 68\u201379. https:\/\/doi.org\/10.1159\/000095511","journal-title":"Cells Tissues Organs"},{"key":"11040_CR146","doi-asserted-by":"publisher","first-page":"748","DOI":"10.4252\/wjsc.v11.i10.748","volume":"11","author":"D Garc\u00eda-S\u00e1nchez","year":"2019","unstructured":"Garc\u00eda-S\u00e1nchez, D., Fern\u00e1ndez, D., Rodr\u00edguez-Rey, J. C., & P\u00e9rez-Campo, F. M. (2019). Enhancing survival, engraftment, and osteogenic potential of mesenchymal stem cells. World J Stem Cells, 11, 748\u2013763. https:\/\/doi.org\/10.4252\/wjsc.v11.i10.748","journal-title":"World J Stem Cells"},{"key":"11040_CR147","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.actbio.2009.10.031","volume":"6","author":"SV Dorozhkin","year":"2010","unstructured":"Dorozhkin, S. V. (2010). Nanosized and nanocrystalline calcium orthophosphates. Acta Biomaterialia, 6, 715\u2013734. https:\/\/doi.org\/10.1016\/j.actbio.2009.10.031","journal-title":"Acta Biomaterialia"},{"key":"11040_CR148","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/25740881.2023.2175222","volume":"62","author":"M Rasouli","year":"2023","unstructured":"Rasouli, M., Hosseinzadeh, S., Mortazavi, S. M., Fattahi, R., Ranjbari, J., & Soleimani, M. (2023). Do carboxymethyl cellulose and pal-KTTKS make bacterial cellulose a superior wound dressing or skin scaffold? Polym Plast Technol Mater, 62, 974\u2013988. https:\/\/doi.org\/10.1080\/25740881.2023.2175222","journal-title":"Polym Plast Technol Mater"},{"key":"11040_CR149","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40778-024-00239-6","volume":"10","author":"F Banche-Niclot","year":"2024","unstructured":"Banche-Niclot, F., Lim, J., McCulloch, P., Corradetti, B., & Taraballi, F. (2024). Mesenchymal stromal cell Immunomodulatory potential for orthopedic applications can be fine-tuned via 3D nano-engineered scaffolds. Current Stem Cell Reports, 10, 65\u201376. https:\/\/doi.org\/10.1007\/s40778-024-00239-6","journal-title":"Current Stem Cell Reports"},{"key":"11040_CR150","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acsabm.8b00434","volume":"2","author":"AS Arabiyat","year":"2019","unstructured":"Arabiyat, A. S., Diaz-Rodriguez, P., Erndt-Marino, J. D., Totsingan, F., Mekala, S., Gross, R. A., & Hahn, M. S. (2019). Effect of Poly(sophorolipid) functionalization on human mesenchymal stem cell osteogenesis and Immunomodulation. ACS Appl Bio Mater, 2, 118\u2013126. https:\/\/doi.org\/10.1021\/acsabm.8b00434","journal-title":"ACS Appl Bio Mater"},{"key":"11040_CR151","doi-asserted-by":"publisher","first-page":"e2000353","DOI":"10.1002\/adhm.202000353","volume":"9","author":"M Deng","year":"2020","unstructured":"Deng, M., Tan, J., Hu, C., Hou, T., Peng, W., Liu, J., Yu, B., et al. (2020). Modification of PLGA scaffold by MSC-Derived extracellular matrix combats macrophage inflammation to initiate bone regeneration via TGF-\u03b2-Induced protein. Adv Healthc Mater, 9, e2000353. https:\/\/doi.org\/10.1002\/adhm.202000353","journal-title":"Adv Healthc Mater"},{"key":"11040_CR152","doi-asserted-by":"publisher","first-page":"670","DOI":"10.5966\/sctm.2015-0233","volume":"5","author":"B Corradetti","year":"2016","unstructured":"Corradetti, B., Taraballi, F., Minardi, S., Van Eps, J., Cabrera, F., Francis, L. W., Gazze, S. A., et al. (2016). Chondroitin sulfate immobilized on a biomimetic scaffold modulates inflammation while driving chondrogenesis. Stem Cells Transl Med, 5, 670\u2013682. https:\/\/doi.org\/10.5966\/sctm.2015-0233","journal-title":"Stem Cells Transl Med"},{"key":"11040_CR153","doi-asserted-by":"publisher","unstructured":"Li, G., Zhou, D., Sheng, S., Lin, Q., Jing, Y., Ren, X., & Su, J. (2024). Hydrogel for bone microenvironment: Strategy and application. Chemical Engineering Journal, 156554. https:\/\/doi.org\/10.1016\/j.cej.2024.156554","DOI":"10.1016\/j.cej.2024.156554"},{"key":"11040_CR154","doi-asserted-by":"publisher","first-page":"128091","DOI":"10.1016\/j.ijbiomac.2023.128091","volume":"256","author":"L Rethi","year":"2024","unstructured":"Rethi, L., Wong, C. C., Liu, W. J., Chen, C. Y., Jheng, P. R., Chen, C. H., & Chuang, E. Y. (2024). Self-adaptable calcium-based bioactive phosphosilicate-infused gelatin-hyaluronic hydrogel for orthopedic regeneration. International Journal of Biological Macromolecules, 256, 128091. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128091","journal-title":"International Journal of Biological Macromolecules"},{"key":"11040_CR155","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fimmu.2015.00648","volume":"6","author":"SF de Witte","year":"2015","unstructured":"de Witte, S. F., Franquesa, M., Baan, C. C., & Hoogduijn, M. J. (2015). Toward development of iMesenchymal stem cells for Immunomodulatory therapy. Frontiers in Immunology, 6, 648. https:\/\/doi.org\/10.3389\/fimmu.2015.00648","journal-title":"Frontiers in Immunology"},{"key":"11040_CR156","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/cr.2008.80","volume":"18","author":"H Sheng","year":"2008","unstructured":"Sheng, H., Wang, Y., Jin, Y., Zhang, Q., Zhang, Y., Wang, L., Shen, B., et al. (2008). A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research, 18, 846\u2013857. https:\/\/doi.org\/10.1038\/cr.2008.80","journal-title":"Cell Research"},{"key":"11040_CR157","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/mt.2009.157","volume":"17","author":"M Rafei","year":"2009","unstructured":"Rafei, M., Birman, E., Forner, K., & Galipeau, J. (2009). Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Molecular Therapy, 17, 1799\u20131803. https:\/\/doi.org\/10.1038\/mt.2009.157","journal-title":"Molecular Therapy"},{"key":"11040_CR158","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3889\/oamjms.2018.404","volume":"6","author":"A Putra","year":"2018","unstructured":"Putra, A., Ridwan, F. B., Putridewi, A. I., Kustiyah, A. R., Wirastuti, K., Sadyah, N. A. C., Rosdiana, I., et al. (2018). The role of TNF-\u03b1 induced MSCs on suppressive inflammation by increasing TGF-\u03b2 and IL-10. Open Access Maced J Med Sci, 6, 1779\u20131783. https:\/\/doi.org\/10.3889\/oamjms.2018.404","journal-title":"Open Access Maced J Med Sci"},{"key":"11040_CR159","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaci.2014.12.1926","volume":"136","author":"W Su","year":"2015","unstructured":"Su, W., Wan, Q., Huang, J., Han, L., Chen, X., Chen, G., Olsen, N., et al. (2015). Culture medium from TNF-\u03b1-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms. The Journal of Allergy and Clinical Immunology, 136, 423\u201332e8. https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1926","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"11040_CR160","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/stem.2075","volume":"33","author":"KN Sivanathan","year":"2015","unstructured":"Sivanathan, K. N., Rojas-Canales, D. M., Hope, C. M., Krishnan, R., Carroll, R. P., Gronthos, S., Grey, S. T., et al. (2015). Interleukin-17A-Induced human mesenchymal stem cells are superior modulators of immunological function. Stem Cells, 33, 2850\u20132863. https:\/\/doi.org\/10.1002\/stem.2075","journal-title":"Stem Cells"},{"key":"11040_CR161","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41419-023-05597-3","volume":"14","author":"Y Liao","year":"2023","unstructured":"Liao, Y., Fu, Z., Huang, Y., Wu, S., Wang, Z., Ye, S., Zeng, W., et al. (2023). Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression. Cell Death and Disease, 14, 66. https:\/\/doi.org\/10.1038\/s41419-023-05597-3","journal-title":"Cell Death and Disease"},{"key":"11040_CR162","doi-asserted-by":"publisher","first-page":"e2395","DOI":"10.1038\/cddis.2016.310","volume":"7","author":"YS Han","year":"2016","unstructured":"Han, Y. S., Lee, J. H., Yoon, Y. M., Yun, C. W., Noh, H., & Lee, S. H. (2016). Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells. Cell Death and Disease, 7, e2395. https:\/\/doi.org\/10.1038\/cddis.2016.310","journal-title":"Cell Death and Disease"},{"key":"11040_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40778-023-00232-5","volume":"10","author":"B Le","year":"2024","unstructured":"Le, B., Cressman, A., Morales, D., & Fierro, F. A. (2024). First clinical experiences using preconditioning approaches to improve MSC-based therapies. Current Stem Cell Reports, 10, 1\u20137. https:\/\/doi.org\/10.1007\/s40778-023-00232-5","journal-title":"Current Stem Cell Reports"},{"key":"11040_CR164","doi-asserted-by":"publisher","first-page":"e10733","DOI":"10.1002\/jbm4.10733","volume":"7","author":"SV Mendoza","year":"2023","unstructured":"Mendoza, S. V., Genetos, D. C., & Yellowley, C. E. (2023). Hypoxia-Inducible Factor-2\u03b1 signaling in the skeletal system. JBMR Plus, 7, e10733. https:\/\/doi.org\/10.1002\/jbm4.10733","journal-title":"JBMR Plus"},{"key":"11040_CR165","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/cvr\/cvt250","volume":"101","author":"WH Huang","year":"2014","unstructured":"Huang, W. H., Chen, H. L., Huang, P. H., Yew, T. L., Lin, M. W., Lin, S. J., & Hung, S. C. (2014). Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients. Cardiovasc Res, 101, 266\u2013276. https:\/\/doi.org\/10.1093\/cvr\/cvt250","journal-title":"Cardiovasc Res"},{"key":"11040_CR166","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.actbio.2019.12.020","volume":"103","author":"W Liu","year":"2020","unstructured":"Liu, W., Li, L., Rong, Y., Qian, D., Chen, J., Zhou, Z., Luo, Y., et al. (2020). Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomaterialia, 103, 196\u2013212. https:\/\/doi.org\/10.1016\/j.actbio.2019.12.020","journal-title":"Acta Biomaterialia"},{"key":"11040_CR167","doi-asserted-by":"publisher","first-page":"e96161","DOI":"10.1371\/journal.pone.0096161","volume":"9","author":"L Chen","year":"2014","unstructured":"Chen, L., Xu, Y., Zhao, J., Zhang, Z., Yang, R., Xie, J., Liu, X., et al. (2014). Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One, 9, e96161. https:\/\/doi.org\/10.1371\/journal.pone.0096161","journal-title":"PLoS One"},{"key":"11040_CR168","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s11658-019-0191-8","volume":"24","author":"X Yu","year":"2019","unstructured":"Yu, X., Wan, Q., Ye, X., Cheng, Y., Pathak, J. L., & Li, Z. (2019). Cellular hypoxia promotes osteogenic differentiation of mesenchymal stem cells and bone defect healing via STAT3 signaling. Cellular & Molecular Biology Letters, 24, 64. https:\/\/doi.org\/10.1186\/s11658-019-0191-8","journal-title":"Cellular & Molecular Biology Letters"},{"key":"11040_CR169","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.51191.2","volume":"10","author":"A Putra","year":"2021","unstructured":"Putra, A., Widyatmoko, A., Ibrahim, S., Amansyah, F., Amansyah, F., Berlian, M. A., Retnaningsih, R., et al. (2021). Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia. F1000Res, 10, 228. https:\/\/doi.org\/10.12688\/f1000research.51191.2","journal-title":"F1000Res"},{"key":"11040_CR170","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ten.TEC.2009.0432","volume":"16","author":"JE Frith","year":"2010","unstructured":"Frith, J. E., Thomson, B., & Genever, P. G. (2010). Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods, 16, 735\u2013749. https:\/\/doi.org\/10.1089\/ten.TEC.2009.0432","journal-title":"Tissue Eng Part C Methods"},{"key":"11040_CR171","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13287-018-1114-8","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu, C., & Li, L. (2019). Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo. Stem Cell Research & Therapy, 10, 13. https:\/\/doi.org\/10.1186\/s13287-018-1114-8","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR172","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/stem.771","volume":"30","author":"K Nemeth","year":"2012","unstructured":"Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Buzas, E., Falus, A., et al. (2012). Characterization and function of Histamine receptors in human bone marrow stromal cells. Stem Cells, 30, 222\u2013231. https:\/\/doi.org\/10.1002\/stem.771","journal-title":"Stem Cells"},{"key":"11040_CR173","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1038\/emm.2014.28","volume":"46","author":"SM Han","year":"2014","unstructured":"Han, S. M., Han, S. H., Coh, Y. R., Jang, G., Chan Ra, J., Kang, S. K., Lee, H. W., et al. (2014). Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Experimental & Molecular Medicine, 46, e101. https:\/\/doi.org\/10.1038\/emm.2014.28","journal-title":"Experimental & Molecular Medicine"},{"key":"11040_CR174","doi-asserted-by":"publisher","first-page":"349","DOI":"10.21873\/invivo.11066","volume":"31","author":"Q Li","year":"2017","unstructured":"Li, Q., Han, S. M., Song, W. J., Park, S. C., Ryu, M. O., & Youn, H. Y. (2017). Anti-inflammatory effects of Oct4\/Sox2-overexpressing human adipose Tissue-derived mesenchymal stem cells. Vivo, 31, 349\u2013356. https:\/\/doi.org\/10.21873\/invivo.11066","journal-title":"Vivo"},{"key":"11040_CR175","doi-asserted-by":"publisher","DOI":"10.2174\/1574888x18666230113144016","author":"M Rasouli","year":"2023","unstructured":"Rasouli, M., Naeimzadeh, Y., Hashemi, N., & Hosseinzadeh, S. (2023). Age-Related alterations in mesenchymal stem cell function: Understanding mechanisms and seeking opportunities to bypass the cellular aging. Curr Stem Cell Res Ther. https:\/\/doi.org\/10.2174\/1574888x18666230113144016","journal-title":"Curr Stem Cell Res Ther"},{"key":"11040_CR176","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3892\/ijmm.2017.3019","volume":"40","author":"X Ni","year":"2017","unstructured":"Ni, X., Ou, C., Guo, J., Liu, B., Zhang, J., Wu, Z., Li, H., et al. (2017). Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro. International Journal of Molecular Medicine, 40, 418\u2013426. https:\/\/doi.org\/10.3892\/ijmm.2017.3019","journal-title":"International Journal of Molecular Medicine"},{"key":"11040_CR177","doi-asserted-by":"publisher","first-page":"300060521997679","DOI":"10.1177\/0300060521997679","volume":"49","author":"Y Hu","year":"2021","unstructured":"Hu, Y., Zhao, Q. W., Wang, Z. C., Fang, Q. Q., Zhu, H., Hong, D. S., Liang, X. G., et al. (2021). Co-transfection with BMP2 and FGF2 via Chitosan nanoparticles potentiates osteogenesis in human adipose-derived stromal cells in vitro. Journal of International Medical Research, 49, 300060521997679. https:\/\/doi.org\/10.1177\/0300060521997679","journal-title":"Journal of International Medical Research"},{"key":"11040_CR178","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3892\/mmr.2017.7183","volume":"16","author":"R Song","year":"2017","unstructured":"Song, R., Wang, D., Zeng, R., & Wang, J. (2017). Synergistic effects of fibroblast growth factor-2 and bone morphogenetic protein-2 on bone induction. Molecular Medicine Reports, 16, 4483\u20134492. https:\/\/doi.org\/10.3892\/mmr.2017.7183","journal-title":"Molecular Medicine Reports"},{"key":"11040_CR179","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13287-020-02086-8","volume":"12","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Lo, C. W., Utsunomiya, T., Maruyama, M., Huang, E., Rhee, C., Gao, Q., et al. (2021). PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration. Stem Cell Research & Therapy, 12, 40. https:\/\/doi.org\/10.1186\/s13287-020-02086-8","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR180","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/stem.1656","volume":"32","author":"H Li","year":"2014","unstructured":"Li, H., Jiang, Y., Jiang, X., Guo, X., Ning, H., Li, Y., Liao, L., et al. (2014). CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: A novel approach to separate GvHD from GvL effect. Stem Cells, 32, 1890\u20131903. https:\/\/doi.org\/10.1002\/stem.1656","journal-title":"Stem Cells"},{"key":"11040_CR181","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7150\/thno.17133","volume":"7","author":"SC Tao","year":"2017","unstructured":"Tao, S. C., Yuan, T., Zhang, Y. L., Yin, W. J., Guo, S. C., & Zhang, C. Q. (2017). Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics, 7, 180\u2013195. https:\/\/doi.org\/10.7150\/thno.17133","journal-title":"Theranostics"},{"key":"11040_CR182","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13287-024-03757-6","volume":"15","author":"S Christoffers","year":"2024","unstructured":"Christoffers, S., Seiler, L., Wiebe, E., & Blume, C. (2024). Possibilities and efficiency of MSC co-transfection for gene therapy. Stem Cell Research & Therapy, 15, 150. https:\/\/doi.org\/10.1186\/s13287-024-03757-6","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR183","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2217\/rme-2023-0089","volume":"18","author":"WH Bouche Djatche","year":"2023","unstructured":"Bouche Djatche, W. H., Zhu, H., Ma, W., Li, Y., Li, Z., Zhao, H., Liu, Z., et al. (2023). Potential of mesenchymal stem cell-derived conditioned medium\/secretome as a therapeutic option for ocular diseases. Regenerative Medicine, 18, 795\u2013807. https:\/\/doi.org\/10.2217\/rme-2023-0089","journal-title":"Regenerative Medicine"},{"key":"11040_CR184","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/stem.3320","volume":"39","author":"HW Caplan","year":"2021","unstructured":"Caplan, H. W., Prabhakara, K. S., Toledano Furman, N. E., Zorofchian, S., Kumar, A., Martin, C., Xue, H., et al. (2021). Combination therapy with Treg and mesenchymal stromal cells enhances potency and Attenuation of inflammation after traumatic brain injury compared to monotherapy. Stem Cells, 39, 358\u2013370. https:\/\/doi.org\/10.1002\/stem.3320","journal-title":"Stem Cells"},{"key":"11040_CR185","doi-asserted-by":"publisher","first-page":"101685","DOI":"10.1016\/j.xcrm.2024.101685","volume":"5","author":"G Grisendi","year":"2024","unstructured":"Grisendi, G., Dall\u2019Ora, M., Casari, G., Spattini, G., Farshchian, M., Melandri, A., Masciale, V., et al. (2024). Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma. Cell Rep Med, 5, 101685. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101685","journal-title":"Cell Rep Med"},{"key":"11040_CR186","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1002\/jbm.b.34019","volume":"106","author":"M Rashtbar","year":"2018","unstructured":"Rashtbar, M., Hadjati, J., Ai, J., Shirian, S., Jahanzad, I., Azami, M., Asadpuor, S., et al. (2018). Critical-sized full-thickness skin defect regeneration using ovine small intestinal submucosa with or without mesenchymal stem cells in rat model. J Biomed Mater Res B Appl Biomater, 106, 2177\u20132190. https:\/\/doi.org\/10.1002\/jbm.b.34019","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"11040_CR187","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13287-017-0716-x","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu, L., Liu, Y., Sun, Y., Wang, B., Xiong, Y., Lin, W., Wei, Q., et al. (2017). Tissue source determines the differentiation potentials of mesenchymal stem cells: A comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Research & Therapy, 8, 275. https:\/\/doi.org\/10.1186\/s13287-017-0716-x","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR188","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede, D. L., Velazquez, J. P., Zambrano, V. Y., Suncion, M., Tracy, et al. (2012). Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. Jama, 308, 2369\u20132379. https:\/\/doi.org\/10.1001\/jama.2012.25321","journal-title":"Jama"},{"key":"11040_CR189","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s43465-022-00751-z","volume":"56","author":"M Jeyaraman","year":"2022","unstructured":"Jeyaraman, M., Muthu, S., Nischith, D. S., Jeyaraman, N., Nallakumarasamy, A., & Khanna, M. (2022). PRISMA-Compliant Meta-Analysis of randomized controlled trials on osteoarthritis of knee managed with allogeneic vs autologous mscs: Efficacy and safety analysis. Indian J Orthop, 56, 2042\u20132059. https:\/\/doi.org\/10.1007\/s43465-022-00751-z","journal-title":"Indian J Orthop"},{"key":"11040_CR190","doi-asserted-by":"publisher","first-page":"19885","DOI":"10.1038\/s41598-024-70382-x","volume":"14","author":"A Bernhardt","year":"2024","unstructured":"Bernhardt, A., Jamil, A., Morshed, M. T., Ponnath, P., Gille, V., Stephan, N., Sauer, H., et al. (2024). Oxidative stress and regulation of adipogenic differentiation capacity by sirtuins in adipose stem cells derived from female patients of advancing age. Scientific Reports, 14, 19885. https:\/\/doi.org\/10.1038\/s41598-024-70382-x","journal-title":"Scientific Reports"},{"key":"11040_CR191","doi-asserted-by":"publisher","unstructured":"Kim, S. M., Kim, Y. H., Jun, Y. J., Yoo, G., & Rhie, J. W. (2016). The effect of diabetes on the wound healing potential of adipose-tissue derived stem cells. Int Wound J 13 Suppl, (1), 33\u201341. https:\/\/doi.org\/10.1111\/iwj.12540","DOI":"10.1111\/iwj.12540"},{"key":"11040_CR192","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s00125-017-4316-1","volume":"60","author":"M Zhu","year":"2017","unstructured":"Zhu, M., He, X., Wang, X. H., Qiu, W., Xing, W., Guo, W., An, T. C., et al. (2017). Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications. Diabetologia, 60, 1822\u20131833. https:\/\/doi.org\/10.1007\/s00125-017-4316-1","journal-title":"Diabetologia"},{"key":"11040_CR193","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.surg.2021.10.057","volume":"171","author":"N Durand","year":"2022","unstructured":"Durand, N., & Zubair, A. C. (2022). Autologous versus allogeneic mesenchymal stem cell therapy: The pros and cons. Surgery, 171, 1440\u20131442. https:\/\/doi.org\/10.1016\/j.surg.2021.10.057","journal-title":"Surgery"},{"key":"11040_CR194","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13578-021-00698-y","volume":"11","author":"C Li","year":"2021","unstructured":"Li, C., Zhao, H., Cheng, L., & Wang, B. (2021). Allogeneic vs. autologous mesenchymal stem\/stromal cells in their medication practice. Cell Biosci, 11, 187. https:\/\/doi.org\/10.1186\/s13578-021-00698-y","journal-title":"Cell Biosci"},{"key":"11040_CR195","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/s0301-472x(00)00160-0","volume":"28","author":"A Banfi","year":"2000","unstructured":"Banfi, A., Muraglia, A., Dozin, B., Mastrogiacomo, M., Cancedda, R., & Quarto, R. (2000). Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Experimental Hematology, 28, 707\u2013715. https:\/\/doi.org\/10.1016\/s0301-472x(00)00160-0","journal-title":"Experimental Hematology"},{"key":"11040_CR196","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3390\/ijms14012119","volume":"14","author":"I Berniakovich","year":"2013","unstructured":"Berniakovich, I., & Giorgio, M. (2013). Low oxygen tension maintains multipotency, whereas normoxia increases differentiation of mouse bone marrow stromal cells. International Journal of Molecular Sciences, 14, 2119\u20132134. https:\/\/doi.org\/10.3390\/ijms14012119","journal-title":"International Journal of Molecular Sciences"},{"key":"11040_CR197","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/stem.139","volume":"27","author":"K Bieback","year":"2009","unstructured":"Bieback, K., Hecker, A., Koca\u00f6mer, A., Lannert, H., Schallmoser, K., Strunk, D., & Kl\u00fcter, H. (2009). Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells, 27, 2331\u20132341. https:\/\/doi.org\/10.1002\/stem.139","journal-title":"Stem Cells"},{"key":"11040_CR198","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13287-023-03589-w","volume":"14","author":"JC Fitzgerald","year":"2023","unstructured":"Fitzgerald, J. C., Shaw, G., Murphy, J. M., & Barry, F. (2023). Media matters: Culture medium-dependent hypervariable phenotype of mesenchymal stromal cells. Stem Cell Research & Therapy, 14, 363. https:\/\/doi.org\/10.1186\/s13287-023-03589-w","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR199","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1634\/stemcells.2005-0094","volume":"23","author":"A Shahdadfar","year":"2005","unstructured":"Shahdadfar, A., Fr\u00f8nsdal, K., Haug, T., Reinholt, F. P., & Brinchmann, J. E. (2005). In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 23, 1357\u20131366. https:\/\/doi.org\/10.1634\/stemcells.2005-0094","journal-title":"Stem Cells"},{"key":"11040_CR200","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3324\/haematol.11446","volume":"92","author":"M Sundin","year":"2007","unstructured":"Sundin, M., Ringd\u00e9n, O., Sundberg, B., Nava, S., G\u00f6therstr\u00f6m, C., & Le Blanc, K. (2007). No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica, 92, 1208\u20131215. https:\/\/doi.org\/10.3324\/haematol.11446","journal-title":"Haematologica"},{"key":"11040_CR201","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4110\/in.2013.13.4.133","volume":"13","author":"HS Yoo","year":"2013","unstructured":"Yoo, H. S., Yi, T., Cho, Y. K., Kim, W. C., Song, S. U., & Jeon, M. S. (2013). Mesenchymal stem cell lines isolated by different isolation methods show variations in the regulation of Graft-versus-host disease. Immune Netw, 13, 133\u2013140. https:\/\/doi.org\/10.4110\/in.2013.13.4.133","journal-title":"Immune Netw"},{"key":"11040_CR202","doi-asserted-by":"publisher","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao, F., Chiu, S. M., Motan, D. A., Zhang, Z., Chen, L., Ji, H. L., Tse, H. F., et al. (2016). Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death and Disease, 7, e2062. https:\/\/doi.org\/10.1038\/cddis.2015.327","journal-title":"Cell Death and Disease"},{"key":"11040_CR203","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13287-021-02249-1","volume":"12","author":"M Zhou","year":"2021","unstructured":"Zhou, M., Xi, J., Cheng, Y., Sun, D., Shu, P., Chi, S., Tian, S., et al. (2021). Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head. Stem Cell Research & Therapy, 12, 175. https:\/\/doi.org\/10.1186\/s13287-021-02249-1","journal-title":"Stem Cell Research & Therapy"},{"key":"11040_CR204","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., et al. (2022). Mesenchymal stem cell-derived extracellular vesicles for Immunomodulation and regeneration: A next generation therapeutic tool? Cell Death and Disease, 13, 580. https:\/\/doi.org\/10.1038\/s41419-022-05034-x","journal-title":"Cell Death and Disease"},{"key":"11040_CR205","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41420-024-01973-w","volume":"10","author":"J Tang","year":"2024","unstructured":"Tang, J., Wang, X., Lin, X., & Wu, C. (2024). Mesenchymal stem cell-derived extracellular vesicles: A regulator and carrier for targeting bone-related diseases. Cell Death Discov, 10, 212. https:\/\/doi.org\/10.1038\/s41420-024-01973-w","journal-title":"Cell Death Discov"},{"key":"11040_CR206","doi-asserted-by":"publisher","first-page":"1383401","DOI":"10.3389\/fsurg.2024.1383401","volume":"11","author":"H Liang","year":"2024","unstructured":"Liang, H., Chen, B., Duan, S., Yang, L., Xu, R., Zhang, H., Sun, M., et al. (2024). Treatment of complex limb fractures with 3D printing technology combined with personalized plates: A retrospective study of case series and literature review. Front Surg, 11, 1383401. https:\/\/doi.org\/10.3389\/fsurg.2024.1383401","journal-title":"Front Surg"},{"key":"11040_CR207","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00264-024-06365-4","volume":"49","author":"B Zhu","year":"2025","unstructured":"Zhu, B., Xue, K., Cai, B., & Fang, J. (2025). Evaluating the outcomes of three dimensional printing-assisted osteotomy on treating varus knee deformity from old tibial plateau fractures. International Orthopaedics, 49, 429\u2013435. https:\/\/doi.org\/10.1007\/s00264-024-06365-4","journal-title":"International Orthopaedics"},{"key":"11040_CR208","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/imr.13236","volume":"320","author":"S Capponi","year":"2023","unstructured":"Capponi, S., & Daniels, K. G. (2023). Harnessing the power of artificial intelligence to advance cell therapy. Immunological Reviews, 320, 147\u2013165. https:\/\/doi.org\/10.1111\/imr.13236","journal-title":"Immunological Reviews"},{"key":"11040_CR209","doi-asserted-by":"publisher","first-page":"913287","DOI":"10.3389\/fmed.2022.913287","volume":"9","author":"S Hort","year":"2022","unstructured":"Hort, S., Herbst, L., B\u00e4ckel, N., Erkens, F., Niessing, B., Frye, M., K\u00f6nig, N., et al. (2022). Toward Rapid, widely available autologous CAR-T cell Therapy - Artificial intelligence and automation enabling the smart manufacturing hospital. Front Med (Lausanne), 9, 913287. https:\/\/doi.org\/10.3389\/fmed.2022.913287","journal-title":"Front Med (Lausanne)"},{"key":"11040_CR210","doi-asserted-by":"publisher","first-page":"663","DOI":"10.5534\/wjmh.210147","volume":"40","author":"J Kang","year":"2022","unstructured":"Kang, J., Song, Y., Zhang, Z., Wang, S., Lu, Y., & Liu, X. (2022). Identification of key MicroRNAs in diabetes mellitus erectile dysfunction rats with stem cell therapy by bioinformatic analysis of deep sequencing data. World J Mens Health, 40, 663\u2013677. https:\/\/doi.org\/10.5534\/wjmh.210147","journal-title":"World J Mens Health"},{"key":"11040_CR211","doi-asserted-by":"publisher","unstructured":"Nosrati, H., & Nosrati, M. (2023). Artificial intelligence in regenerative medicine: Applications and implications. Biomimetics (Basel), 8. https:\/\/doi.org\/10.3390\/biomimetics8050442","DOI":"10.3390\/biomimetics8050442"},{"key":"11040_CR212","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.transci.2018.05.004","volume":"57","author":"I Sniecinski","year":"2018","unstructured":"Sniecinski, I., & Seghatchian, J. (2018). Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine. Transfus Apher Sci, 57, 422\u2013424. https:\/\/doi.org\/10.1016\/j.transci.2018.05.004","journal-title":"Transfus Apher Sci"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11040-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:16:48Z","timestamp":1769750208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":212,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11040"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11040-1","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}